Quick Listen: Scrip’s Five Must-Know Things
In this week's episode: melanoma win for Moderna's mRNA candidate; lung cancer victory for Enhertu; measuring industry R&D productivity; Enveda's post-GLP-1 contender; and the factors behind China's rise.
Scrip - August 24, 2026

Two FDA Convenience Kit Alerts Linked To Huons Drug Components
Back-to-back safety alerts from the FDA involving medical kits containing drugs manufactured by Huons Co., highlight the agency's continuing concern over the South Korean company’s pharmaceutical products. The alerts affect surgical and epidural kits containing recalled drugs from the firm.
Medtech Insight - August 21, 2026

AI Could Transform Surgery. Bad Incentives May Keep It For The Wealthy Few.
J&J Medtech's new report argues that surgical AI's biggest obstacles are no longer technical — they are economic incentives, fragmented governance and a financing model that makes hospitals pay while payers capture the gains.
Medtech Insight - August 21, 2026

CMS Grants NTAP For Aidoc’s Foundation-Model AI — A First For Broad Diagnostic Tools
CMS has granted Aidoc's CARE Body CT Multi-Triage an NTAP worth $137.53 per qualifying Medicare inpatient scan — the first such payment for a broad, multi-finding, foundation-model AI, covering many conditions at once rather than one disease at a time.
Medtech Insight - August 21, 2026

EU PPWR: Minimizing Medtech Packaging Without Losing Protection
Starting in 2030, the PPWR prohibits unnecessary empty spaces and decorative fillers. In medtech, where size affects sterility, stability, and handling, every void must have a purpose, not just aim for zero empty space. Experts advise that proper documentation is key, and the time to begin is now.
Medtech Insight - August 21, 2026

Pinworm Treatment Marketer Scratches Claims For Efficacy Against Other Intestinal Parasites
Wellspring Meds discontinues express claims for Pin Rid challenged by PinWorm marketer Reese Consumer Health but maintains claims to also treat roundworms, hookworms, whipworms, threadworms and tapeworms are accurate.
HBW Insight - August 24, 2026

Silo Locks Down IP Rights For PTSD Asset As It Prepares 505(b)(2) Filing
?In a bid to shorten clinical timelines and reduce costs, Silo Pharma plans to use?the?Food and Drug Administration’s streamlined 505(b)(2) regulatory pathway to push forward with its PTSD treatment.? Meanwhile a Canadian patent has been granted following hot on the heels of a European patent.
Generics Bulletin - August 21, 2026

Richter Sees GenMed Recovery Stretching Into 2027
Richter expects its General Medicines business to return to mid-single-digit growth from 2027, with newer generics helping offset legacy-product erosion, distributor changes and market-specific setbacks that weighed on first-half performance.
Generics Bulletin - August 21, 2026

Glenmark Builds On US Respiratory Portfolio With Generic Flonase Nasal Spray Approval
The latest FDA approval of a fluticasone propionate nasal spray further secures Glenmark’s ambition to resurrect its US presence with an expansive respiratory product portfolio.
Generics Bulletin - August 21, 2026

Sawai Launches Four First-Time Generics As Revenue Rises But Profit Falls In Q1
Sawai Pharmaceuticals records early revenue growth but falling operating profit in its first-quarter earnings report for a new fiscal year.
Generics Bulletin - August 21, 2026

Three Strategies US Device Makers Are Using To Stem Staff Burnout And Turnover
Corporate medtech industry employee engagement has slipped to a decade low. In 2026, leading medtech firms abandoned generic HR programs in favor of mission-linked leadership, adaptive capacity building and authentic manager communication to stem staff burnout and turnover.
In Vivo - August 24, 2026